{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T11:19:49Z","timestamp":1764674389307,"version":"3.46.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["# PICT2019-00504"],"award-info":[{"award-number":["# PICT2019-00504"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005363","name":"University of Buenos Aires","doi-asserted-by":"crossref","award":["UBACYT2020\/20020190100194BA"],"award-info":[{"award-number":["UBACYT2020\/20020190100194BA"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26952-8","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T11:17:06Z","timestamp":1764674226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GITR triggering has limited impact on HIV-specific CD8 T-cell function but enhances HIV transcription reactivation from latently infected CD4 T-cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Alejandro","family":"Czernikier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Baquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Benencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Osorio Ocampo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimena","family":"Salido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda I.","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Laufer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanina","family":"Ghiglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda F.","family":"Pascutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Turk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"26952_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41572-023-00452-3","volume":"9","author":"L-G Bekker","year":"2023","unstructured":"Bekker, L-G. et al. HIV infection. Nat. Rev. Dis. Primers. 9, 42. https:\/\/doi.org\/10.1038\/s41572-023-00452-3 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"26952_CR2","doi-asserted-by":"publisher","unstructured":"McMyn, N. F. et al. The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy. J. Clin. Invest. 133 https:\/\/doi.org\/10.1172\/JCI171554 (2023).","DOI":"10.1172\/JCI171554"},{"key":"26952_CR3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMoa0802905","volume":"360","author":"G H\u00fctter","year":"2009","unstructured":"H\u00fctter, G. et al. Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation. N Engl. J. Med. 360, 692\u2013698. https:\/\/doi.org\/10.1056\/NEJMoa0802905 (2009).","journal-title":"N Engl. J. Med."},{"key":"26952_CR4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-023-02213-x","volume":"29","author":"B-E-O Jensen","year":"2023","unstructured":"Jensen, B-E-O. et al. In-depth virological and immunological characterization of HIV-1 cure after CCR5\u220632\/\u220632 allogeneic hematopoietic stem cell transplantation. Nat. Med. 29, 583\u2013587. https:\/\/doi.org\/10.1038\/s41591-023-02213-x (2023).","journal-title":"Nat. Med."},{"key":"26952_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.7326\/L21-0297","volume":"175","author":"G Turk","year":"2022","unstructured":"Turk, G. et al. A possible sterilizing cure of HIV-1 infection without stem cell transplantation. Ann. Intern. Med. 175, 95\u2013100. https:\/\/doi.org\/10.7326\/L21-0297 (2022).","journal-title":"Ann. Intern. Med."},{"key":"26952_CR6","doi-asserted-by":"publisher","unstructured":"S\u00e1ez-Ciri\u00f3n, A. et al. Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells. Nat. Med. 1\u201311. https:\/\/doi.org\/10.1038\/s41591-024-03277-z (2024).","DOI":"10.1038\/s41591-024-03277-z"},{"key":"26952_CR7","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s41591-021-01590-5","volume":"27","author":"SG Deeks","year":"2021","unstructured":"Deeks, S. G. et al. Research priorities for an HIV cure: International AIDS society global scientific strategy 2021. Nat. Med. 27, 2085\u20132098. https:\/\/doi.org\/10.1038\/s41591-021-01590-5 (2021).","journal-title":"Nat. Med."},{"key":"26952_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","volume":"23","author":"Y Kim","year":"2018","unstructured":"Kim, Y., Anderson, J. L. & Lewin, S. R. Getting the kill into shock and kill: Strategies to eliminate latent HIV. Cell. Host Microbe 23, 14\u201326. https:\/\/doi.org\/10.1016\/j.chom.2017.12.004 (2018).","journal-title":"Cell. Host Microbe"},{"key":"26952_CR9","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.immuni.2016.04.022","volume":"44","author":"J Attanasio","year":"2016","unstructured":"Attanasio, J. & Wherry, E. J. Costimulatory and coinhibitory receptor pathways in infectious disease. Immunity 44, 1052\u20131068. https:\/\/doi.org\/10.1016\/j.immuni.2016.04.022 (2016).","journal-title":"Immunity"},{"key":"26952_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/COH.0000000000000748","volume":"17","author":"RL Rutishauser","year":"2022","unstructured":"Rutishauser, R. L. & Trautmann, L. CD8\u2009+\u2009T-cell responses in HIV controllers: Potential implications for novel HIV remission strategies. Curr. Opin. HIV AIDS 17, 315\u2013324. https:\/\/doi.org\/10.1097\/COH.0000000000000748 (2022).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"26952_CR11","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S0140-6736(19)32990-3","volume":"395","author":"S Fidler","year":"2020","unstructured":"Fidler, S. et al. Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): A phase 2, randomised trial. Lancet 395, 888\u2013898. https:\/\/doi.org\/10.1016\/S0140-6736(19)32990-3 (2020).","journal-title":"Lancet"},{"key":"26952_CR12","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3390\/v14071571","volume":"14","author":"G Curty","year":"2022","unstructured":"Curty, G., Iniguez, L. P., Soares, M. A., Nixon, D. F. & de Mulder Rougvie, M. Off-target effect of activation of NF-\u03baB by HIV latency reversal agents on transposable elements expression. Viruses 14, 1571. https:\/\/doi.org\/10.3390\/v14071571 (2022).","journal-title":"Viruses"},{"key":"26952_CR13","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/s41467-021-21563-z","volume":"12","author":"F Wang","year":"2021","unstructured":"Wang, F. et al. Structures of mouse and human GITR-GITRL complexes reveal unique TNF superfamily interactions. Nat. Commun. 12, 1378. https:\/\/doi.org\/10.1038\/s41467-021-21563-z (2021).","journal-title":"Nat. Commun."},{"key":"26952_CR14","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/eji.200636933","volume":"37","author":"G Nocentini","year":"2007","unstructured":"Nocentini, G., Ronchetti, S., Cuzzocrea, S. & Riccardi, C. GITR\/GITRL: More than an effector T cell co-stimulatory system. Eur. J. Immunol. 37, 1165\u20131169. https:\/\/doi.org\/10.1002\/eji.200636933 (2007).","journal-title":"Eur. J. Immunol."},{"key":"26952_CR15","doi-asserted-by":"publisher","first-page":"108165","DOI":"10.1016\/j.isci.2023.108165","volume":"26","author":"C Gubser","year":"2023","unstructured":"Gubser, C. et al. GITR activation ex vivo impairs CD8 T cell function in people with HIV on antiretroviral therapy. iScience 26, 108165. https:\/\/doi.org\/10.1016\/j.isci.2023.108165 (2023).","journal-title":"iScience"},{"key":"26952_CR16","doi-asserted-by":"publisher","unstructured":"Nocentini, G., Cari, L. & Riccardi, C. GITR: A modulator of regulatory and effector T-cell activity, crucial in tumour rejection and autoimmune diseases. 1\u201311 (Wiley, 2017). https:\/\/doi.org\/10.1002\/9780470015902.a0026242.","DOI":"10.1002\/9780470015902.a0026242"},{"key":"26952_CR17","doi-asserted-by":"publisher","first-page":"7490","DOI":"10.4049\/jimmunol.0802751","volume":"182","author":"RW van Olffen","year":"2009","unstructured":"van Olffen, R. W. et al. GITR triggering induces expansion of both effector and regulatory CD4\u2009+\u2009T cells in vivo. J. Immunol. 182, 7490\u20137500. https:\/\/doi.org\/10.4049\/jimmunol.0802751 (2009).","journal-title":"J. Immunol."},{"key":"26952_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/intimm\/dxq001","volume":"22","author":"G Liao","year":"2010","unstructured":"Liao, G. et al. GITR engagement preferentially enhances proliferation of functionally competent CD4\u2009+\u2009CD25\u2009+\u2009FoxP3\u2009+\u2009regulatory T cells. Int. Immunol. 22, 259\u2013270. https:\/\/doi.org\/10.1093\/intimm\/dxq001 (2010).","journal-title":"Int. Immunol."},{"key":"26952_CR19","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.4049\/jimmunol.0802597","volume":"183","author":"A Wyzgol","year":"2009","unstructured":"Wyzgol, A. et al. Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand. J. Immunol. 183, 1851\u20131861. https:\/\/doi.org\/10.4049\/jimmunol.0802597 (2009).","journal-title":"J. Immunol."},{"key":"26952_CR20","doi-asserted-by":"publisher","first-page":"614","DOI":"10.18632\/oncotarget.28461","volume":"14","author":"D Davar","year":"2023","unstructured":"Davar, D. & Zappasodi, R. Targeting GITR in cancer immunotherapy\u2014There is no perfect knowledge. Oncotarget 14, 614\u2013621. https:\/\/doi.org\/10.18632\/oncotarget.28461 (2023).","journal-title":"Oncotarget"},{"key":"26952_CR21","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.3389\/fimmu.2018.02443","volume":"9","author":"J Salido","year":"2018","unstructured":"Salido, J. et al. Phenotype, polyfunctionality, and antiviral activity of in vitro stimulated CD8\u2009+\u2009T-cells from HIV\u2009+\u2009subjects who initiated cART at different time-points after acute infection. Front. Immunol. 9, 2443. https:\/\/doi.org\/10.3389\/fimmu.2018.02443 (2018).","journal-title":"Front. Immunol."},{"key":"26952_CR22","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/326711a0","volume":"326","author":"G Nabel","year":"1987","unstructured":"Nabel, G. & Baltimore, D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711\u2013713. https:\/\/doi.org\/10.1038\/326711a0 (1987).","journal-title":"Nature"},{"key":"26952_CR23","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.1073\/pnas.94.12.6216","volume":"94","author":"G Nocentini","year":"1997","unstructured":"Nocentini, G. et al. A new member of the tumor necrosis factor\/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc. Natl. Acad. Sci. U S A. 94, 6216\u20136221. https:\/\/doi.org\/10.1073\/pnas.94.12.6216 (1997).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"26952_CR24","doi-asserted-by":"publisher","first-page":"1129191","DOI":"10.3389\/fimmu.2023.1129191","volume":"14","author":"MA Daniels","year":"2023","unstructured":"Daniels, M. A., Luera, D. & Teixeiro, E. NF\u03baB signaling in T cell memory. Front. Immunol. 14, 1129191. https:\/\/doi.org\/10.3389\/fimmu.2023.1129191 (2023).","journal-title":"Front. Immunol."},{"key":"26952_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","volume":"443","author":"CL Day","year":"2006","unstructured":"Day, C. L. et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350\u2013354. https:\/\/doi.org\/10.1038\/nature05115 (2006).","journal-title":"Nature"},{"key":"26952_CR26","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/nm1482","volume":"12","author":"L Trautmann","year":"2006","unstructured":"Trautmann, L. et al. Upregulation of PD-1 expression on HIV-specific CD8\u2009+\u2009T cells leads to reversible immune dysfunction. Nat. Med. 12, 1198\u20131202. https:\/\/doi.org\/10.1038\/nm1482 (2006).","journal-title":"Nat. Med."},{"key":"26952_CR27","doi-asserted-by":"publisher","unstructured":"SalidoJP et al. Early skewed differentiation and PD-1 expression in CD4\u2009+\u2009cells relate to immune dysfunction and viral persistence in individuals living with HIV 1 year post-cART initiation. J. Virus Eradication https:\/\/doi.org\/10.1016\/S2055-6640(20)31026-8 (2019).","DOI":"10.1016\/S2055-6640(20)31026-8"},{"key":"26952_CR28","doi-asserted-by":"publisher","unstructured":"Buckheit, R. W. 3, Salgado, M., Silciano, R. F., Blankson, J. N. & rd,, Inhibitory potential of subpopulations of CD8\u2009+\u2009T cells in HIV-1-infected elite suppressors. J. Virol. 86, 13679\u201313688. https:\/\/doi.org\/10.1128\/JVI.02439-12 (2012).","DOI":"10.1128\/JVI.02439-12"},{"key":"26952_CR29","doi-asserted-by":"publisher","unstructured":"Takata, H. et al. Delayed differentiation of potent effector CD8\u2009+\u2009T cells reducing viremia and reservoir seeding in acute HIV infection. Sci. Transl. Med. 9 https:\/\/doi.org\/10.1126\/scitranslmed.aag1809 (2017).","DOI":"10.1126\/scitranslmed.aag1809"},{"key":"26952_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/35065118","volume":"410","author":"P Champagne","year":"2001","unstructured":"Champagne, P. et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410, 106\u2013111. https:\/\/doi.org\/10.1038\/35065118 (2001).","journal-title":"Nature"},{"key":"26952_CR31","doi-asserted-by":"publisher","first-page":"e104235","DOI":"10.1371\/journal.pone.0104235","volume":"9","author":"Y Ghiglione","year":"2014","unstructured":"Ghiglione, Y. et al. Early skewed distribution of total and HIV-specific CD8\u2009+\u2009T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progression. PLoS One 9, e104235. https:\/\/doi.org\/10.1371\/journal.pone.0104235 (2014).","journal-title":"PLoS One"},{"key":"26952_CR32","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.4049\/jimmunol.1102695","volume":"188","author":"D Masopust","year":"2012","unstructured":"Masopust, D. & Picker, L. J. Hidden memories: Frontline memory T cells and early pathogen interception. J. Immunol. 188, 5811\u20135817. https:\/\/doi.org\/10.4049\/jimmunol.1102695 (2012).","journal-title":"J. Immunol."},{"key":"26952_CR33","doi-asserted-by":"publisher","unstructured":"Salido, J. et al. Pre-cART immune parameters in people living with HIV might help predict CD8\u2009+\u2009T-cell characteristics, inflammation levels, and reservoir composition after effective cART. Pathog. Immun. 6, 60\u201389. https:\/\/doi.org\/10.20411\/pai.v6i2.447 (2021).","DOI":"10.20411\/pai.v6i2.447"},{"key":"26952_CR34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature10003","volume":"473","author":"SG Hansen","year":"2011","unstructured":"Hansen, S. G. et al. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473, 523\u2013527. https:\/\/doi.org\/10.1038\/nature10003 (2011).","journal-title":"Nature"},{"key":"26952_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1600-065X.2011.01063.x","volume":"244","author":"LM Snell","year":"2011","unstructured":"Snell, L. M., Lin, G. H. Y., McPherson, A. J., Moraes, T. J. & Watts, T. H. T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy: Effects of GITR and 4-1BB on T cells. Immunol. Rev. 244, 197\u2013217. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01063.x (2011).","journal-title":"Immunol. Rev."},{"key":"26952_CR36","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.4049\/jimmunol.1401002","volume":"193","author":"DL Clouthier","year":"2014","unstructured":"Clouthier, D. L., Zhou, A. C. & Watts, T. H. Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC. J. Immunol. 193, 5033\u20135043. https:\/\/doi.org\/10.4049\/jimmunol.1401002 (2014).","journal-title":"J. Immunol."},{"key":"26952_CR37","doi-asserted-by":"publisher","first-page":"e1004675","DOI":"10.1371\/journal.ppat.1004675","volume":"11","author":"MF Pascutti","year":"2015","unstructured":"Pascutti, M. F. et al. Enhanced CD8 T cell responses through GITR-mediated costimulation resolve chronic viral infection. PLoS Pathog. 11, e1004675. https:\/\/doi.org\/10.1371\/journal.ppat.1004675 (2015).","journal-title":"PLoS Pathog"},{"key":"26952_CR38","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.4049\/jimmunol.1200602","volume":"189","author":"AW Mailloux","year":"2012","unstructured":"Mailloux, A. W. et al. Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome. J. Immunol. 189, 3198\u20133208. https:\/\/doi.org\/10.4049\/jimmunol.1200602 (2012).","journal-title":"J. Immunol."},{"key":"26952_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1182\/blood-2012-07-409755","volume":"121","author":"MF Chevalier","year":"2013","unstructured":"Chevalier, M. F. & Weiss, L. The split personality of regulatory T cells in HIV infection. Blood 121, 29\u201337. https:\/\/doi.org\/10.1182\/blood-2012-07-409755 (2013).","journal-title":"Blood"},{"key":"26952_CR40","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1111\/j.1365-2567.2008.02978.x","volume":"128","author":"Y Jiao","year":"2009","unstructured":"Jiao, Y. et al. The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8\u2009+\u2009T cells in HIV-1-infected typical progressors, but not in long-term non-progressors. Immunology 128, e366\u2013e375. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.02978.x (2009).","journal-title":"Immunology"},{"key":"26952_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1086\/518613","volume":"196","author":"TP Lahey","year":"2007","unstructured":"Lahey, T. P., Loisel, S. D. & Wieland-Alter, W. Glucocorticoid-induced tumor necrosis factor receptor family-related protein triggering enhances HIV-specific CD4\u2009+\u2009T cell cytokine secretion and protects HIV-specific CD4\u2009+\u2009T cells from apoptosis. J. Infect. Dis. 196, 43\u201349. https:\/\/doi.org\/10.1086\/518613 (2007).","journal-title":"J. Infect. Dis."},{"key":"26952_CR42","doi-asserted-by":"publisher","unstructured":"Mylvaganam, G. H. et al. Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV. JCI Insight 3 https:\/\/doi.org\/10.1172\/jci.insight.122940 (2018).","DOI":"10.1172\/jci.insight.122940"},{"key":"26952_CR43","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nm.1972","volume":"15","author":"N Chomont","year":"2009","unstructured":"Chomont, N. et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15, 893\u2013900. https:\/\/doi.org\/10.1038\/nm.1972 (2009).","journal-title":"Nat. Med."},{"key":"26952_CR44","doi-asserted-by":"publisher","first-page":"101438","DOI":"10.1016\/j.smim.2020.101438","volume":"51","author":"R Fromentin","year":"2021","unstructured":"Fromentin, R. & Chomont, N. HIV persistence in subsets of CD4\u2009+\u2009T cells: 50 shades of reservoirs. Semin Immunol. 51, 101438. https:\/\/doi.org\/10.1016\/j.smim.2020.101438 (2021).","journal-title":"Semin Immunol."},{"key":"26952_CR45","doi-asserted-by":"publisher","unstructured":"Duette, G. et al. The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4\u2009+\u2009T cells. J. Clin. Invest. 132 https:\/\/doi.org\/10.1172\/JCI154422 (2022).","DOI":"10.1172\/JCI154422"},{"key":"26952_CR46","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.celrep.2017.09.081","volume":"21","author":"B Hiener","year":"2017","unstructured":"Hiener, B. et al. Identification of genetically intact HIV-1 proviruses in specific CD4\u2009+\u2009T cells from effectively treated participants. Cell. Rep. 21, 813\u2013822. https:\/\/doi.org\/10.1016\/j.celrep.2017.09.081 (2017).","journal-title":"Cell. Rep."},{"key":"26952_CR47","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.4049\/jimmunol.179.9.5916","volume":"179","author":"S Ronchetti","year":"2007","unstructured":"Ronchetti, S. et al. Glucocorticoid-induced TNFR-related protein lowers the threshold of CD28 costimulation in CD8\u2009+\u2009T cells. J. Immunol. 179, 5916\u20135926. https:\/\/doi.org\/10.4049\/jimmunol.179.9.5916 (2007).","journal-title":"J. Immunol."},{"key":"26952_CR48","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.molimm.2007.05.013","volume":"45","author":"EM Bae","year":"2008","unstructured":"Bae, E. M. et al. Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages. Mol. Immunol. 45, 523\u2013533. https:\/\/doi.org\/10.1016\/j.molimm.2007.05.013 (2008).","journal-title":"Mol. Immunol."},{"key":"26952_CR49","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.tim.2015.01.013","volume":"23","author":"KM Bruner","year":"2015","unstructured":"Bruner, K. M., Hosmane, N. N. & Siliciano, R. F. Towards an HIV-1 cure: Measuring the latent reservoir. Trends Microbiol. 23, 192\u2013203. https:\/\/doi.org\/10.1016\/j.tim.2015.01.013 (2015).","journal-title":"Trends Microbiol."},{"key":"26952_CR50","doi-asserted-by":"publisher","unstructured":"Takata, H. et al. Modeling HIV-1 latency using primary CD4\u2009+\u2009T cells from virally suppressed HIV-1-infected individuals on antiretroviral therapy. J. Virol. 93. https:\/\/doi.org\/10.1128\/JVI.02248-18 (2019).","DOI":"10.1128\/JVI.02248-18"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26952-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26952-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26952-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T11:17:08Z","timestamp":1764674228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26952-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26952"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26952-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work the authors used ChatGPT in order to improve the readability and language of the manuscript as none of the authors are native English speakers. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}}],"article-number":"43002"}}